HOME > Investor Relations > Financial Information > Financial Highlights

Financial Information

Financial Highlights


(Unit : Thousands of yen)

Accounting Term 16th 17th 18th 19th 20th
Fiscal Period FY2014/3
As of March 31, 2014
(Consolidated)
FY2015/3
As of March 31, 2015
(Consolidated)
FY2016/3
As of March 31, 2016
(Consolidated)
FY2017/3
As of March 31, 2017
(Consolidated)
FY2018/3
As of March 31, 2018
(Consolidated)
Net sales 1,617,572 1,958,554 2,290,287 2,302,908 3,601,283
Genomics Business 385,702 296,738 395,050 420,148 299,045
CRO Business 670,133 799,183 1,099,367 1,150,505 1,000,662
Advanced Medical Business 312,995 482,062 391,779 356,587 412,355
Pathological Diagnostics Business 251,711 396,779 413,778 399,294 395,627
TGBS Business 1,505,360
Operating income △ 85,022 23,693 50,413 153,948 60,554
Net income △ 113,642 17,824 14,587 80,694 20,898
 
Total assets 3,563,800 3,573,785 3,905,445 3,902,426 5,934,680
Net assets 2,764,943 2,777,287 3,069,782 3,173,327 4,341,825
Shareholders' equity 2,700,072 2,764,739 3,042,942 3,194,745 4,261,110
Shareholders' equity to total assets (%) 75.8 77.4 78.2 81.0 73.0
 
ROE: Return on equity (%) △ 4.2 0.6 0.5 2.5 0.5
EPS: Net income per share (JPY) △ 8.39 1.29 1.05 5.63 1.41
BPS: Book-value per share (JPY) 198.21 198.81 214.27 220.20 265.64
PBR: Price bookvalue ratio 2.1 2.0 3.7 2.8 1.9
 
Shares outstanding (Share) 13,624,100 13,908,641 14,246,941 14,246,941 16,303,941
Market capitalization 5,613,129 5,577,365 11,426,046 8,957,483 8,396,530
 
Cash flows from operating activities △ 141,502 101,241 214,367 232,813 219,059
Cash flows from investing activities △ 174,871 △ 46,550 △ 664,721 △ 200,101 △ 552,120
Cash flows from financing activities 371,304 △ 92,697 157,921 △ 27,298 1,044,975
Cash and cash equivalents at end of year 1,384,192 1,346,185 1,053,753 1,059,180 1,772,500
 
Number of employees (persons) 132 132 141 137 162

Financial Information

Financial Highlights
Financial Highlights

Information on consolidated business performance and financial position.

Consolidated Balance Sheets
Consolidated Balance Sheets

Consolidated balance sheets.

Consolidated of Statements Income
Consolidated of Statements Income

Consolidated statements of income.

Consolidated Statements of Cash Flows
Consolidated Statements of Cash Flows

Consolidated statements of cash flows.

  • Press Releases
Contact Us/Products&ServicesE-mail
  • Reproductive Technology Training
Back to Top